Moderna's coronavirus vaccine shows encouraging early results - The Washington Post
PDF) Modified mRNA Vaccines Protect against Zika Virus Infection
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Nanomaterials | Free Full-Text | Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives | HTML
Current Status of COVID‐19 (Pre)Clinical Vaccine Development - Ye - 2020 - Angewandte Chemie International Edition - Wiley Online Library
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
PDF) mRNA vaccines — a new era in vaccinology
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses: Molecular Therapy
Michael J. Hogan's research works | The Children's Hospital of Philadelphia, PA (CHOP) and other places
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Nanotechnology for COVID-19: Therapeutics and Vaccine Research. - Abstract - Europe PMC
FDA approves potential COVID-19 vaccine by Moderna for second-stage study - UPI.com
PDF) Generating an Anti-HIV Vaccine Using Nucleoside-modified mRNA Encoding Envelope
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Moderna Therapeutics — Wikipédia
PDF) Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
Crowd fund launched for 'Battlestar Galactica' actor Michael Hogan after brain injury
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
Moderna's coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities - The Washington Post
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. - Abstract - Europe PMC
